JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2017 • Cormorant Asset Management, LLC • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2017 Company IndustryThis Joint Filing Agreement, dated as of February 14, 2017, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 28th, 2020 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
Contract Type FiledDecember 28th, 2020 Company IndustryThis Joint Filing Agreement, dated as of December 28, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 16th, 2023 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledNovember 16th, 2023 Company IndustryThis Joint Filing Agreement, dated as of November 16, 2023, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • March 26th, 2021 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledMarch 26th, 2021 Company IndustryThis Joint Filing Agreement, dated as of March 26, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 19th, 2021 • Cormorant Asset Management, LP • Services-medical laboratories
Contract Type FiledJanuary 19th, 2021 Company IndustryThis Joint Filing Agreement, dated as of January 19, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 12th, 2020 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledNovember 12th, 2020 Company IndustryThis Joint Filing Agreement, dated as of November 12, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • October 23rd, 2023 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledOctober 23rd, 2023 Company IndustryThis Joint Filing Agreement, dated as of October 23, 2023, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2017 • Cormorant Asset Management, LLC • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2017 Company IndustryThis Joint Filing Agreement, dated as of February 14, 2017, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 20th, 2020 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledJuly 20th, 2020 Company IndustryThis Joint Filing Agreement, dated as of July 20, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2019 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2019 Company IndustryThis Joint Filing Agreement, dated as of February 14, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • August 15th, 2016 • Cormorant Asset Management, LLC • Pharmaceutical preparations
Contract Type FiledAugust 15th, 2016 Company IndustryThis Joint Filing Agreement, dated as of August 15, 2016, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • April 27th, 2020 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledApril 27th, 2020 Company IndustryThis Joint Filing Agreement, dated as of April 27, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • April 25th, 2019 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledApril 25th, 2019 Company IndustryThis Joint Filing Agreement, dated as of April 25, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 2nd, 2018 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
Contract Type FiledJuly 2nd, 2018 Company IndustryThis Joint Filing Agreement, dated as of July 2, 2018, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the "Filers").
JOINT FILING AGREEMENTJoint Filing Agreement • July 8th, 2021 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
Contract Type FiledJuly 8th, 2021 Company IndustryThis Joint Filing Agreement, dated as of July 8, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 2nd, 2021 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
Contract Type FiledJuly 2nd, 2021 Company IndustryThis Joint Filing Agreement, dated as of July 2, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 30th, 2021 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledJuly 30th, 2021 Company IndustryThis Joint Filing Agreement, dated as of July 30, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 7th, 2019 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
Contract Type FiledNovember 7th, 2019 Company IndustryThis Joint Filing Agreement, dated as of November 7, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • October 16th, 2020 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
Contract Type FiledOctober 16th, 2020 Company IndustryThis Joint Filing Agreement, dated as of October 16, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 30th, 2017 • Cormorant Asset Management, LLC • Pharmaceutical preparations
Contract Type FiledJanuary 30th, 2017 Company IndustryThis Joint Filing Agreement, dated as of January 30, 2017, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 29th, 2022 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledDecember 29th, 2022 Company IndustryThis Joint Filing Agreement, dated as of December 29, 2022, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 7th, 2022 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledJuly 7th, 2022 Company IndustryThis Joint Filing Agreement, dated as of July 7, 2022, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 16th, 2019 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledDecember 16th, 2019 Company IndustryThis Joint Filing Agreement, dated as of December 16, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • June 17th, 2022 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
Contract Type FiledJune 17th, 2022 Company IndustryThis Joint Filing Agreement, dated as of June 17, 2022, is by and among Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2024 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2024 Company IndustryThis Joint Filing Agreement, dated as of February 14, 2024, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 2nd, 2018 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledJuly 2nd, 2018 Company IndustryThis Joint Filing Agreement, dated as of July 2, 2018, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • August 29th, 2022 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
Contract Type FiledAugust 29th, 2022 Company IndustryThis Joint Filing Agreement, dated as of August 29, 2022, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • November 13th, 2020 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledNovember 13th, 2020 Company IndustryThis Joint Filing Agreement, dated as of November 13, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
ContractJoint Filing Agreement • September 11th, 2017 • Cormorant Asset Management, LLC • Pharmaceutical preparations
Contract Type FiledSeptember 11th, 2017 Company Industry
JOINT FILING AGREEMENTJoint Filing Agreement • September 29th, 2016 • Cormorant Asset Management, LLC • Pharmaceutical preparations
Contract Type FiledSeptember 29th, 2016 Company IndustryThis Joint Filing Agreement, dated as of September 29, 2016, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 12th, 2021 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledJuly 12th, 2021 Company IndustryThis Joint Filing Agreement, dated as of July 12, 2021, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • April 22nd, 2019 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
Contract Type FiledApril 22nd, 2019 Company IndustryThis Joint Filing Agreement, dated as of April 22, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • April 21st, 2017 • Cormorant Asset Management, LLC • Pharmaceutical preparations
Contract Type FiledApril 21st, 2017 Company IndustryThis Joint Filing Agreement, dated as of April 21, 2017, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund I, LP, Cormorant Private Healthcare GP, LLC, Cormorant Asset Management, LLC and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Cormorant Asset Management, LP • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2022 Company IndustryThis Joint Filing Agreement, dated as of February 14, 2022, is by and between Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • May 20th, 2019 • Cormorant Asset Management, LP • Blank checks
Contract Type FiledMay 20th, 2019 Company IndustryThis Joint Filing Agreement, dated as of May 20, 2019, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).